Advertisement
Loading...

Qiagen N.V.

QGEN•NYSE
Healthcare
Medical - Diagnostics & Research
$32.98
$-0.31(-0.93%)
U.S. Market opens in 37h 19m

Qiagen N.V. (QGEN) Stock Overview

Explore Qiagen N.V.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap6.8B
P/E Ratio16.98
EPS (TTM)$1.96
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 Month$44.90
3 Months$50.63
1 Year Target$49.23

QGEN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Qiagen N.V. (QGEN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 32.42, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $49.23.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 16.98 and a market capitalization of 6.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.90%
5-Day Change
-1.35%
1-Month Change
-20.77%
3-Month Change
-34.56%
6-Month Change
-25.56%
Year-to-Date (YTD) Change
-30.31%
1-Year Change
-21.90%
3-Year Change
-27.81%
5-Year Change
-29.87%
All-Time (Max) Change
1566.16%

Contact Information

https://www.qiagen.com
31 77 355 6600
Hulsterweg 82, Venlo, NaN, 5912 PL

Company Facts

5,700 Employees
IPO DateJun 28, 1996
CountryNL
Actively Trading

Frequently Asked Questions